| Financial Year |
March 31 2023 |
| Monetary Funds |
350,570,978.84 |
| Held-for-trading Financial Assets |
43,030,416.67 |
| Notes Receivable |
174,688,164.69 |
| Accounts Receivable |
538,095,099.04 |
| Advances to Suppliers |
20,347,414.00 |
| Other Receivables |
3,967,606.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
450,482,141.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,515,898.91 |
| Total Current Assets |
1,767,792,862.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
6,077,790.09 |
| Fixed Assetes |
423,210,292.95 |
| Under-construction Projects |
10,056,698.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,961,240.22 |
| R&D expenses |
-- |
| Goodwill |
54,994,026.29 |
| Long-Term Deferred and Prepaid Expenses |
4,607,880.50 |
| Deferred Income Tax Assets |
17,856,632.02 |
| Other Non-Current Assets |
7,253,773.44 |
| Sub-Total of Non-Current Assets |
638,517,350.25 |
| Total Assets |
2,406,310,212.33 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
551,093,444.55 |
| Accounts Payable |
259,795,018.66 |
| Accounts Received In Advance |
181,400.00 |
| Employee Compensation Payable |
8,852,217.39 |
| Taxes Payable |
16,597,581.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
52,809,190.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
976,146.93 |
| Other Current Liabilities |
1,479,019.55 |
| Sub-Total of Current Liabilities |
903,242,657.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,156,875.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,361,170.74 |
| Total Liabilities |
949,603,828.60 |
| Paid-In Capital(Or Share Stock) |
306,726,517.00 |
| Capital Surplus |
426,159,352.84 |
| Surplus Reserve |
95,002,077.02 |
| LESS:Treasury Stock |
104,950,681.30 |
| Undistributed Profits |
701,821,770.51 |
| Minority Stockholder's Interest |
29,017,620.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,427,688,762.93 |
| Owner's Equity（Stockholder's Equity） |
1,456,706,383.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,406,310,212.33 |
